Qiming Injects $16M In Berry Genomics’ Series B Round
April 3, 2015 — 13:59 CST
This Data Is Locked!
This area is available only to Subscribers.
Beijing-based biotechnology firm Berry Genomics Co., Limited has completed RMB100 million (US$16 million) series B financing from Qiming Venture Partners, according to Chinese media reports.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
